Literature DB >> 10072487

Fas ligand-mediated exocrinopathy resembling Sjögren's syndrome in mice transgenic for IL-10.

I Saito1, K Haruta, M Shimuta, H Inoue, H Sakurai, K Yamada, N Ishimaru, H Higashiyama, T Sumida, H Ishida, T Suda, T Noda, Y Hayashi, K Tsubota.   

Abstract

Although IL-10 has been implicated in the pathogenesis of several autoimmune diseases, the mechanisms by which this cytokine mediates inflammatory lesions remain to be elucidated. Exocrine gland destruction is an important early step in the development of Sjögren's syndrome. To better understand the role of IL-10 in Sjögren's syndrome, we made transgenic mice in which the mouse IL-10 gene was regulated by the human salivary amylase promoter. Transgenic expression of IL-10 induced apoptosis of glandular tissue destruction and lymphocyte infiltration consisting primarily of Fas-ligand (FasL)+ CD4+ T cells, as well as in vitro up-regulation of FasL expression on T cells. These data suggest that overexpression of IL-10 in the glands and their subsequent Fas/FasL-mediated bystander tissue destruction is a causal factor in the development of this disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10072487

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Severe destructive autoimmune lesions with aging in murine Sjögren's syndrome through Fas-mediated apoptosis.

Authors:  N Ishimaru; T Yoneda; K Saegusa; K Yanagi; N Haneji; K Moriyama; I Saito; Y Hayashi
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

Review 2.  Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment.

Authors:  B M Lodde; B J Baum; P P Tak; G Illei
Journal:  Ann Rheum Dis       Date:  2006-07-31       Impact factor: 19.103

3.  Novel role for RbAp48 in tissue-specific, estrogen deficiency-dependent apoptosis in the exocrine glands.

Authors:  Naozumi Ishimaru; Rieko Arakaki; Fumie Omotehara; Koichi Yamada; Kenji Mishima; Ichiro Saito; Yoshio Hayashi
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 4.  Animal models of Sjögren's syndrome.

Authors:  Malin V Jonsson; Nicolas Delaleu; Roland Jonsson
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

5.  IL-15 converts human intestinal intraepithelial lymphocytes to CD94 producers of IFN-gamma and IL-10, the latter promoting Fas ligand-mediated cytotoxicity.

Authors:  Ellen C Ebert
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

Review 6.  The value of animal models to study immunopathology of primary human Sjögren's syndrome symptoms.

Authors:  Amy Donate; Alexandria Voigt; Cuong Q Nguyen
Journal:  Expert Rev Clin Immunol       Date:  2014-02-10       Impact factor: 4.473

7.  Participation of the Fas and Fas ligand systems in apoptosis during atrophy of the rat submandibular glands.

Authors:  Shigeru Takahashi; Glenda C Gobe; Yoshitaka Yoshimura; Takao Kohgo; Tsuneyuki Yamamoto; Minoru Wakita
Journal:  Int J Exp Pathol       Date:  2007-02       Impact factor: 1.925

8.  Suppressive effect of locally produced interleukin-10 on respiratory syncytial virus infection.

Authors:  Y Ruan; Y Okamoto; Z Matsuzaki; S Endo; T Matsuoka; T Kohno; H Chazono; I Eiko; K Tsubota; I Saito
Journal:  Immunology       Date:  2001-11       Impact factor: 7.397

9.  Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity.

Authors:  Kaoru Saegusa; Naozumi Ishimaru; Kumiko Yanagi; Rieko Arakaki; Kouichi Ogawa; Ichiro Saito; Nobuhiko Katunuma; Yoshio Hayashi
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

10.  Interleukin-6 inhibits apoptosis of exocrine gland tissues under inflammatory conditions.

Authors:  Jing Zhou; Jun-O Jin; Ekta S Patel; Qing Yu
Journal:  Cytokine       Date:  2015-08-05       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.